News
FLHLF
0.0001
NaN%
--
Weekly Report: what happened at FLHLF last week (0406-0410)?
Weekly Report · 3d ago
Weekly Report: what happened at FLHLF last week (0330-0403)?
Weekly Report · 04/06 10:11
Weekly Report: what happened at FLHLF last week (0323-0327)?
Weekly Report · 03/30 10:11
Weekly Report: what happened at FLHLF last week (0316-0320)?
Weekly Report · 03/23 10:08
Psychedelic: AtaiBeckley reports publication of BPL-003 study results
TipRanks · 03/19 15:45
Magdalena initiates preclinical study of coca for appetite suppression
TipRanks · 03/16 13:15
Weekly Report: what happened at FLHLF last week (0309-0313)?
Weekly Report · 03/16 10:08
Red Light Holland to Acquire Filament Health, Building Integrated Natural Psychedelic Drug Platform
TipRanks · 03/10 22:40
Weekly Report: what happened at FLHLF last week (0302-0306)?
Weekly Report · 03/09 10:08
Weekly Report: what happened at FLHLF last week (0223-0227)?
Weekly Report · 03/02 10:07
Weekly Report: what happened at FLHLF last week (0216-0220)?
Weekly Report · 02/23 10:07
Weekly Report: what happened at FLHLF last week (0209-0213)?
Weekly Report · 02/16 10:07
Weekly Report: what happened at FLHLF last week (0202-0206)?
Weekly Report · 02/09 10:08
Weekly Report: what happened at FLHLF last week (0126-0130)?
Weekly Report · 02/02 10:08
Weekly Report: what happened at FLHLF last week (0119-0123)?
Weekly Report · 01/26 10:08
Weekly Report: what happened at FLHLF last week (0112-0116)?
Weekly Report · 01/19 10:13
Weekly Report: what happened at FLHLF last week (0105-0109)?
Weekly Report · 01/12 10:13
Weekly Report: what happened at FLHLF last week (1229-0102)?
Weekly Report · 01/05 10:07
Weekly Report: what happened at FLHLF last week (1222-1226)?
Weekly Report · 12/29/2025 10:07
Weekly Report: what happened at FLHLF last week (1215-1219)?
Weekly Report · 12/22/2025 10:07
More
Webull provides a variety of real-time FLHLF stock news. You can receive the latest news about Filament Health through multiple platforms. This information may help you make smarter investment decisions.
About FLHLF
Filament Health Corp. is a Canada-based clinical-stage natural psychedelic drug development company. The Company’s platform of intellectual property enables the discovery, development, and delivery of natural psychedelic medicines. The Company’s first three botanical drug candidates are standardized, purified extracts of Psilocybe cubensis fruiting bodies include: PEX010 Psilocybin - oral delivery (1mg and 25mg), PEX020 Psilocin - oral delivery (dose withheld), and PEX030 Psilocin - sublingual delivery (dose withheld). The Company's preclinical stage drug candidates include AEX010 Ayahuasca - oral delivery (dose withheld), and AEX020 Monoamine Oxidase Inhibitor - oral delivery (dose withheld). The Company’s internal drug discovery and development program is carried out by its wholly owned subsidiary, Psilo Scientific Ltd., and is focused on developing standardized pharmaceutical-grade drug candidates from botanical psychedelic biomass.